FaF:F0VC_FAF Research activities - Course Information
F0VC_FAF Research activities
Faculty of PharmacySpring 2024
- Extent and Intensity
- 0/0/0. 30 credit(s) (from 5 credits increase by 5). Type of Completion: z (credit).
- Guaranteed by
- doc. Ing. Pavel Bobáľ, CSc.
Faculty of Pharmacy - Prerequisites (in Czech)
- FAKULTA(FaF)
- Course Enrolment Limitations
- The course is also offered to the students of the fields other than those the course is directly associated with.
- fields of study / plans the course is directly associated with
- Safety and Quality of Drugs (programme FaF, D-BKL) (2)
- Medicinal Chemistry (programme FaF, D-FCH) (2)
- Pharmaceutical Technology (programme FaF, D-FT) (2)
- Pharmacognosy (programme FaF, D-Fg) (2)
- Pharmacology and Toxicology (programme FaF, D-PhT) (2)
- Medicinal Chemistry (programme FaF, D-FCHA) (2)
- Pharmaceutical Technology (programme FaF, D-FTA) (2)
- Pharmacognosy (programme FaF, D-FgA) (2)
- Course objectives
- Evaluation of student's research activities.
- Learning outcomes
- Obtained patent / utility model. Successfully defended grant.
- Syllabus
- Preparation of the applied result and / or grant proposal and work on this.
- Teaching methods
- Consultation of research activities with the supervisor.
- Assessment methods
- Credit according to point value: patent (author, co-author) - 30 credits, successfully defended grant - researcher - 15 credits, successfully defended grant - co-researcher - 5 credits. To obtain the credit, it is necessary to send a document confirming a patent or a successfully defended grant to phd@pharm.muni.cz.
- Language of instruction
- Czech
- Further comments (probably available only in Czech)
- The course can also be completed outside the examination period.
The course is taught each semester.
Credit evaluation note: patent (autor, spoluautor) - 30 kreditů, úspěšně obhájený grant - řešitel - 15 kreditů, úspěšně obhájený grant - spoluřešitel - 5 kreditů.
- Enrolment Statistics (Spring 2024, recent)
- Permalink: https://is.muni.cz/course/pharm/spring2024/F0VC_FAF